IP Library Granted Patent US 9,249,441
Granted Patent B2
US 9,249,441 · App. 14/474,244 · Granted Feb 2, 2016

Tailored oils

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,249,441
App. No.
14/474,244
Granted
Feb 2, 2016
Kind
B2
Abstract

Recombinant DNA techniques are used to produce oleaginous recombinant cells that produce triglyceride oils having desired fatty acid profiles and regiospecific or stereospecific profiles. Genes manipulated include those encoding stearoyl-ACP desturase, delta 12 fatty acid desaturase, acyl-ACP thioesterase, ketoacyl-ACP synthase, and lysophosphatidic acid acyltransferase. The oil produced can have enhanced oxidative or thermal stability, or can be useful as a frying oil, shortening, roll-in shortening, tempering fat, cocoa butter replacement, as a lubricant, or as a feedstock for various chemical processes. The fatty acid profile can be enriched in midchain profiles or the oil can be enriched in triglycerides of the saturated-unsaturated-saturated type.

Claims (3)

1. A recombinant vector or isolated host cell comprising recombinant nucleic acids encoding a protein having at least 90% identity to SEQ ID NO: 77, wherein the protein has lysophosphatidic acid acyltransferase (LPAAT) activity.

2. A recombinant vector or isolated host cell comprising recombinant nucleic acids encoding a protein having at least 90% identity to SEQ ID NO: 78, wherein the protein has lysophosphatidic acid acyltransferase (LPAAT) activity.

3. A recombinant vector or isolated host cell comprising recombinant nucleic acids encoding a protein having at least 90% identity to SEQ ID NO: 79, wherein the protein has lysophosphatidic acid acyltransferase (LPAAT) activity.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 3, 2017
From: TERRAVIA HOLDINGS, INC.
To: CORBION BIOTECH, INC.
Reel/Frame 044424/0211 →
CHANGE OF NAME Recorded May 23, 2016
From: SOLAZYME, INC.
To: TERRAVIA HOLDINGS, INC.
Reel/Frame 038794/0867 →